FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10626211000001103: Natalizumab 300mg/15ml solution for injection vials 1 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36252001000001118 Natalizumab 300mg/15ml solution for injection vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
52721901000001113 Natalizumab 300mg/15ml solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Natalizumab 300mg/15ml solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Is pack of Natalizumab 300mg injection solution 15mL vial false Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has active ingredient Natalizumab false Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has VMP Natalizumab 300mg injection solution 15mL vial false Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has specific active ingredient Natalizumab true Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has VMP Natalizumab 300mg/15ml solution for infusion vials false Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for injection vials 1 vial Has VMP Natalizumab 300mg/15ml solution for infusion vials true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tysabri 300mg/15ml concentrate for solution for infusion vials (Biogen Ltd) 1 vial Is a True Natalizumab 300mg/15ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start